The Gregory Foundation for Cancer Research Partners with Oncoheroes Biosciences to Advance Pediatric Drug Development
NEWS PROVIDED BY
The Gregory Foundation for Cancer Research
May 27, 2020, 08:00 ET
/New York, May 27, 2020/
-- The Gregory Foundation, a charitable organization dedicated to find cures for cancers affecting children, announces a strategic partnership with Oncoheroes Biosciences.
This investment will help accelerate the clinical drug development of volasertib, one of Oncoheroes’ assets, propelling it into a Phase Ib-II clinical trial for Rhabdomyosarcoma, a very aggressive form of pediatric cancer. Volasertib, was licensed by Oncoheroes from Boehringer Ingelheim and has potential for other pediatric cancer indications.
“We need more innovative treatments that reach the clinic quicker and for this, all efforts are needed. As a nonprofit, we decided to not only fund academic research but also to invest in a company that has a clear path, solid team and strong connections in pediatric oncology and is committed to quickly bringing new drugs to market specifically designed for children with cancer” explained Sonsy P. Rajan, President and Founder of The Gregory Foundation for Cancer Research.
“To date, only four drugs have been specifically developed and approved for pediatric cancer, thus forcing oncologists to use in children cancer treatments that were mainly developed for adult cancers. We want to thank The Gregory Foundation for Cancer Research for believing in our approach and we hope that this partnership would bring multiple cures to children affected by cancers” stated Ricardo Garcia, CEO of Oncoheroes.
The Gregory Foundation for Cancer Research was born out of one infant's fight against infantile leukemia. Gregory was born May 11, 2016 and was diagnosed with infant Leukemia when he was just 10 months of age. He fought the disease for 11 months and passed away on March 21, 2018. Although Gregory received cutting edge immunotherapies and targeted therapies, including CAR-T 19 and allogeneic CAR-T, the disease was very aggressive, and ultimately succumbed to the cancer. --
About Gregory Foundation for Cancer Research and Oncoheroes Biosciences.
The Gregory Foundation is a 501(c)3 charitable organization dedicated to support oncology drug development and access to medicine initiatives for children affected by cancer in the US and around the world. The Foundation epitomizes Gregory, his love and life. Through partnerships with leading academic institutions, hospitals and large and small life sciences companies, the Foundation is actively participating in drug development for pediatric oncology and access to medicine initiatives in innovative ways.
Oncoheroes is a ground-breaking biotech company exclusively focused on the discovery and development of better drugs for children and adolescents with cancer. Our vision is to deliver benefits to young cancer patients and create value in the process. The company is headquartered in Boston, USA. The company was co-founded by Ricardo Garcia (serial entrepreneur), Cesare Spadoni (drug development professional), Marc Goldberg (savvy Life Science VC investor) and Marco Muñoz (seasoned fundraiser). The management team is formed by drug development and industry professionals in the US and Europe and the company has already established strong links with the major international pediatric oncology network as well as the childhood cancer community at large.
CONTACT: Sonsy P. Rajan, srajan@gregoryfoundation.org
SOURCE: The Gregory Foundation for Cancer Research.
Related Links